Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
202.71
-2.65 (-1.29%)
Jan 7, 2026, 4:00 PM EST - Market closed

BDX Revenue

In the fiscal year ending September 30, 2025, Becton, Dickinson and Company had annual revenue of $21.84B with 8.24% growth. Becton, Dickinson and Company had revenue of $5.89B in the quarter ending September 30, 2025, with 8.33% growth.

Revenue (ttm)
$21.84B
Revenue Growth
+8.24%
P/S Ratio
2.67
Revenue / Employee
$303,333
Employees
72,000
Market Cap
57.75B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202521.84B1.66B8.24%
Sep 30, 202420.18B806.00M4.16%
Sep 30, 202319.37B502.00M2.66%
Sep 30, 202218.87B-261.00M-1.36%
Sep 30, 202119.13B3.06B19.02%
Sep 30, 202016.07B-1.22B-7.03%
Sep 30, 201917.29B1.31B8.18%
Sep 30, 201815.98B3.89B32.17%
Sep 30, 201712.09B-390.00M-3.12%
Sep 30, 201612.48B2.20B21.41%
Sep 30, 201510.28B1.84B21.74%
Sep 30, 20148.45B392.00M4.87%
Sep 30, 20138.05B346.00M4.49%
Sep 30, 20127.71B124.00M1.64%
Sep 30, 20117.58B459.62M6.45%
Sep 30, 20107.12B137.66M1.97%
Sep 30, 20096.99B89.10M1.29%
Sep 30, 20086.90B614.78M9.79%
Sep 30, 20076.28B544.82M9.49%
Sep 30, 20065.74B397.18M7.44%
Sep 30, 20055.34B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings